Evidence map›Paper›PMID 36751494›Full record

ArticleGlomerular diseases2021

Association between Psychiatric Disorders and Glomerular Disease.

Hailey E Desmond, Clare Lindner, Jonathan P Troost, Zack Held, Andrea Callaway, Gia J Oh, Richard Lafayette, Michelle O'Shaughnessy, Matthew Elliott, Sharon G Adler and 7 more

Open access · goldAbstract read
In one paragraph

Article in Glomerular diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

Hailey E DesmondDivision of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Clare LindnerDivision of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Jonathan P TroostMichigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, Michigan, USA.
Zack HeldDivision of Pediatric Nephrology, Department of Pediatrics, Levine Children's Hospital, Atrium Health, Charlotte, North Carolina, USA.
Andrea CallawayNephrotic Syndrome Foundation, Alamo, California, USA.
Gia J OhDepartment of Pediatric Nephrology, Randall Children's Hospital at Legacy Emanuel Medical Center, Legacy Health, Portland, Oregon, USA.
Richard LafayetteDivision of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA.
Michelle O'ShaughnessyUniversity College Cork, Cork University Hospital, Cork, Ireland.
Matthew ElliottMetrolina Nephrology Associates, Charlotte, North Carolina, USA.
Sharon G AdlerDivision of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-University of California, Torrance, California, USA.
Elaine S KamilDivision of Pediatric Nephrology, Department of Pediatrics, Cedars-Sinai Medical Center, David Geffen School of Medicine at the University of California, Los Angeles, California, USA.
Anne PesensonThe Polyclinic, Seattle, Washington, USA.
David T SelewskiDivision of Nephrology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.
Patrick E GipsonDivision of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Noelle E CarlozziDepartment of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, Michigan, USA.
Debbie S GipsonDivision of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Susan F MassengillDivision of Pediatric Nephrology, Department of Pediatrics, Levine Children's Hospital, Atrium Health, Charlotte, North Carolina, USA.
University of Michigan · USLevine Children's Hospital · USCedars-Sinai Medical Center · USLegacy Emanuel Medical Center · USMedical University of South Carolina · USRome Foundation · USStanford University · USThe Lundquist Institute · USUniversity College Cork · IE

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
NCATS NIH HHS UL1 TR002240
6 · The paper itself

Abstract

Introduction: Patients with chronic health conditions, particularly chronic kidney disease, are at heightened risk for psychiatric disorders; yet, there are limited data on those with primary glomerular disease. Methods: This study included patients with glomerular disease enrolled in the kidney research network multisite patient registry. Registry data include encounter, diagnoses, medication, laboratory, and vital signs data extracted from participants' electronic health records. ICD-9/10 diagnosis codes were used to identify a subset of psychiatric disorders focused on anxiety, mood, and behavioral disorders. Time-varying Cox proportional hazard models were used to analyze time from the onset of kidney disease to diagnosis of psychiatric disorder. Adjusted models retained significant covariates from the full list of potential confounders, including age, sex, race, ethnicity, time-varying treatment, the estimated glomerular filtration rate, and proteinuria (urine protein-to-creatinine ratio [UPCR]). Analogous models examined diagnosis of psychiatric disorder as a predictor of time to end-stage kidney disease (ESKD). Results: Data were available for 950 participants, with a median of 58 months of follow-up. 110 (12%) participants were diagnosed with psychiatric disorder during the follow-up. The estimated rate of psychiatric diagnosis after kidney disease was 14.7 cases per 1,000 person-years and was highest among those of adolescent age at the time of kidney disease diagnosis. Adjusted analyses found adolescent age (vs. adult, hazard ratio [HR] = 3.11, 95% confidence interval [CI] 1.87-5.17) and Asian race (vs. white, HR = 0.34, 95% CI 0.16-0.71) were associated with psychiatric diagnosis. A higher UPCR per 1 log unit (HR 1.13, 95% CI 1.01-1.27) and a higher total number of oral medications were associated with psychiatric disorder ( Discussion/Conclusion: Psychiatric disorders were documented in approximately one-eighth of patients with glomerular disease and correlated with clinical disease characteristics such as age, race, proteinuria, and oral medication burden. These findings suggest mental health screening is warranted in patients of all ages with glomerular disease.

Indexed as

AnxietyElectronic health recordEnd-stage kidney diseaseGlomerular diseaseNephrotic syndromePsychiatric disorder

Identifiers

PMID36751494
PMCPMC9677713
OpenAlexW3180566204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.